Advances in Intraoperative Glioma Tissue Sampling and Infiltration Assessment
Open Access
- 25 November 2023
- journal article
- review article
- Published by MDPI AG in Brain Sciences
- Vol. 13 (12) , 1637
Abstract
Gliomas are infiltrative brain tumors that often involve functional tissue. While maximal safe resection is critical for maximizing survival, this is challenged by the difficult intraoperative discrimination between tumor-infiltrated and normal structures. Surgical expertise is essential for identifying safe margins, and while the intraoperative pathological review of frozen tissue is possible, this is a time-consuming task. Advances in intraoperative stimulation mapping have aided surgeons in identifying functional structures and, as such, has become the gold standard for this purpose. However, intraoperative margin assessment lacks a similar consensus. Nonetheless, recent advances in intraoperative imaging techniques and tissue examination methods have demonstrated promise for the accurate and efficient assessment of tumor infiltration and margin delineation within the operating room, respectively. In this review, we describe these innovative technologies that neurosurgeons should be aware of.Keywords
This publication has 86 references indexed in Scilit:
- 5-Aminolevulinic Acid Induced Fluorescence Is a Powerful Intraoperative Marker for Precise Histopathological Grading of Gliomas with Non-Significant Contrast-EnhancementPLOS ONE, 2013
- Serum Biomarkers Identification by Mass Spectrometry in High-Mortality TumorsInternational Journal of Proteomics, 2013
- Classifying Human Brain Tumors by Lipid Imaging with Mass SpectrometryCancer Research, 2012
- Characterization of eight different tetracyclines: advances in fluorescence bone labelingJournal of Anatomy, 2010
- Molecular Analysis of Tumor Margins by MALDI Mass Spectrometry in Renal CarcinomaJournal of Proteome Research, 2010
- Imaging mass spectrometryMass Spectrometry Reviews, 2007
- Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trialThe Lancet Oncology, 2006
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Protein Profiling in Brain Tumors Using Mass SpectrometryClinical Cancer Research, 2004
- Fluorescence-guided resection of glioblastoma multiforme by using high-dose fluorescein sodiumJournal of Neurosurgery, 2003